Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants II: role of plasma esterases in drug release.
作者信息
Lu Xiuling, Howard Melissa D, Talbert Dominique R, Rinehart John J, Potter Philip M, Jay Michael, Leggas Markos
机构信息
Division of Molecular Pharmaceutics, University of North Carolina, Chapel Hill, North Carolina 27599-3560, USA.
出版信息
AAPS J. 2009 Mar;11(1):120-2. doi: 10.1208/s12248-009-9086-3. Epub 2009 Feb 19.
Abstract
摘要
相似文献
1
Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants II: role of plasma esterases in drug release.含抗炎剂的纳米颗粒作为化疗佐剂II：血浆酯酶在药物释放中的作用
AAPS J. 2009 Mar;11(1):120-2. doi: 10.1208/s12248-009-9086-3. Epub 2009 Feb 19.
2
Nanoscale Lipophilic Prodrugs of Dexamethasone with Enhanced Pharmacokinetics.具有增强药代动力学的地塞米松的纳米级亲脂前药。
Mol Pharm. 2019 Jul 1;16(7):2999-3010. doi: 10.1021/acs.molpharmaceut.9b00237. Epub 2019 Jun 4.
3
Steady-state pharmacokinetics of corticosteroid delivery from glucuronide prodrugs in normal and colitic rats.
Biopharm Drug Dispos. 1997 Nov;18(8):681-95. doi: 10.1002/(sici)1099-081x(199711)18:8<681::aid-bdd56>3.0.co;2-a.
4
[Pharmacokinetics of site-specific delivery of dexamethasone-dextran prodrug in rat gastrointestinal tract].[地塞米松-右旋糖酐前药在大鼠胃肠道的位点特异性递送的药代动力学]
Yao Xue Xue Bao. 2001 May;36(5):325-8.
5
[Study on the enzyme dependant colon targeting prodrug--dexamethasone succinate dextran and its tablets].
Yao Xue Xue Bao. 2001 Aug;36(8):625-30.
6
Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants: optimization and in vitro characterization.含有抗炎剂作为化疗佐剂的纳米颗粒：优化及体外表征
AAPS J. 2008;10(1):133-40. doi: 10.1208/s12248-008-9013-z. Epub 2008 Mar 4.
7
Dexamethasone 21-sulfate improves the therapeutic properties of dexamethasone against experimental rat colitis by specifically delivering the steroid to the large intestine.21-硫酸地塞米松通过将类固醇特异性递送至大肠，改善了地塞米松对实验性大鼠结肠炎的治疗特性。
Pharm Res. 2009 Feb;26(2):415-21. doi: 10.1007/s11095-008-9758-1. Epub 2008 Oct 29.
8
Characterization of esterases involved in the stereoselective hydrolysis of ester-type prodrugs of propranolol in rat liver and plasma.大鼠肝脏和血浆中参与普萘洛尔酯型前药立体选择性水解的酯酶的特性研究。
Chirality. 1999;11(1):10-3. doi: 10.1002/(SICI)1520-636X(1999)11:1<10::AID-CHIR2>3.0.CO;2-E.
9
Nanoparticle delivery of an SN38 conjugate is more effective than irinotecan in a mouse model of neuroblastoma.在神经母细胞瘤小鼠模型中，纳米颗粒递送SN38偶联物比伊立替康更有效。
Cancer Lett. 2015 May 1;360(2):205-12. doi: 10.1016/j.canlet.2015.02.011. Epub 2015 Feb 12.
10
Modular Acid-Activatable Acetone-Based Ketal-Linked Nanomedicine by Dexamethasone Prodrugs for Enhanced Anti-Rheumatoid Arthritis with Low Side Effects.基于二甲双胍前药的模块化酸激活丙酮缩酮连接纳米医学用于增强抗类风湿关节炎作用且副作用低。
Nano Lett. 2020 Apr 8;20(4):2558-2568. doi: 10.1021/acs.nanolett.9b05340. Epub 2020 Mar 13.
引用本文的文献
1
Polybasic nanogels for intracellular co-delivery of paclitaxel and carboplatin: a novel approach to ovarian cancer therapy.用于紫杉醇和卡铂细胞内共递送的多元纳米凝胶：卵巢癌治疗的新方法。
RSC Pharm. 2025 Feb 21;2(3):553-569. doi: 10.1039/d4pm00330f. eCollection 2025 May 20.
2
Self-Assembled Nanostructured Lipid Systems: Is There a Link between Structure and Cytotoxicity?自组装纳米结构脂质体系：结构与细胞毒性之间存在关联吗？
Adv Sci (Weinh). 2018 Nov 12;6(3):1801223. doi: 10.1002/advs.201801223. eCollection 2019 Feb 6.
3
Increased Body Exposure to New Anti-Trypanosomal Through Nanoencapsulation.通过纳米封装增加新型抗锥虫药物的全身暴露量。
Sci Rep. 2017 Aug 16;7(1):8429. doi: 10.1038/s41598-017-08469-x.
4
Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy.用于NQO1靶向肺癌治疗的酯酶可激活的β-拉帕醌前药胶束
J Control Release. 2015 Feb 28;200:201-11. doi: 10.1016/j.jconrel.2014.12.027. Epub 2014 Dec 24.
5
Nanocarriers for vascular delivery of anti-inflammatory agents.用于抗炎药物血管递送的纳米载体。
Annu Rev Pharmacol Toxicol. 2014;54:205-26. doi: 10.1146/annurev-pharmtox-011613-140002.
6
High payload dual therapeutic-imaging nanocarriers for triggered tumor delivery.高载量双治疗-成像纳米载体用于触发肿瘤递送。
Small. 2012 Sep 24;8(18):2895-903. doi: 10.1002/smll.201200437. Epub 2012 Jul 6.
本文引用的文献
1
Intensive anti-inflammatory therapy with dexamethasone in patients with non-small cell lung cancer: effect on chemotherapy toxicity and efficacy.地塞米松强化抗炎治疗对非小细胞肺癌患者化疗毒性及疗效的影响
Cancer Chemother Pharmacol. 2009 Mar;63(4):731-43. doi: 10.1007/s00280-008-0767-x. Epub 2008 May 24.
2
Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants: optimization and in vitro characterization.含有抗炎剂作为化疗佐剂的纳米颗粒：优化及体外表征
AAPS J. 2008;10(1):133-40. doi: 10.1208/s12248-008-9013-z. Epub 2008 Mar 4.
3
Stability in plasmas of various species of HPMA copolymer-PGE1 conjugates.不同种类的HPMA共聚物 - PGE1缀合物在血浆中的稳定性。
Pharm Res. 2007 Dec;24(12):2270-80. doi: 10.1007/s11095-007-9449-3. Epub 2007 Sep 25.
4
Enzymes involved in the bioconversion of ester-based prodrugs.参与酯基前药生物转化的酶。
J Pharm Sci. 2006 Jun;95(6):1177-95. doi: 10.1002/jps.20542.
5
Stability of oxymethyl-modified coumarinic acid cyclic prodrugs of diastereomeric opioid peptides in biological media from various animal species including human.包括人类在内的各种动物物种的生物介质中，非对映体阿片肽的氧甲基修饰香豆酸环前药的稳定性。
J Pharm Sci. 2005 Oct;94(10):2198-206. doi: 10.1002/jps.20452.
6
Pretreatment with dexamethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts: in vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy.
Clin Cancer Res. 2004 Mar 1;10(5):1633-44. doi: 10.1158/1078-0432.ccr-0829-3.
7
Dexamethasone as a chemoprotectant in cancer chemotherapy: hematoprotective effects and altered pharmacokinetics and tissue distribution of carboplatin and gemcitabine.地塞米松作为癌症化疗中的化学保护剂：对卡铂和吉西他滨的血液保护作用以及药代动力学和组织分布的改变
Cancer Chemother Pharmacol. 2004 Jun;53(6):459-67. doi: 10.1007/s00280-003-0759-9. Epub 2004 Jan 30.
8
Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties.隐形脂质体与长循环纳米颗粒：药代动力学、调理作用及蛋白结合特性中的关键问题
Prog Lipid Res. 2003 Nov;42(6):463-78. doi: 10.1016/s0163-7827(03)00033-x.
9
Hematopoietic protection by dexamethasone or granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients treated with carboplatin and ifosfamide.地塞米松或粒细胞巨噬细胞集落刺激因子（GM-CSF）对接受卡铂和异环磷酰胺治疗患者的造血保护作用。
Am J Clin Oncol. 2003 Oct;26(5):448-58. doi: 10.1097/01.coc.0000027268.23258.7D.
10
Reduction in carboplatin hematopoietic toxicity in tumor bearing mice: comparative mechanisms and effects of interleukin-1 beta and corticosteroids.携带肿瘤小鼠中卡铂造血毒性的降低：白细胞介素-1β与皮质类固醇的比较机制及效果
Cancer Biother Radiopharm. 1997 Apr;12(2):101-9. doi: 10.1089/cbr.1997.12.101.
Zotero 插件